IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.289
NA - Nord America 7.962
AS - Asia 5.206
SA - Sud America 1.826
AF - Africa 142
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.802
RU - Federazione Russa 5.114
SG - Singapore 2.397
BR - Brasile 1.570
CN - Cina 1.361
SE - Svezia 1.197
IE - Irlanda 1.169
HK - Hong Kong 625
FR - Francia 558
DE - Germania 538
IT - Italia 467
UA - Ucraina 381
GB - Regno Unito 307
VN - Vietnam 269
FI - Finlandia 230
PL - Polonia 115
IN - India 99
BD - Bangladesh 92
AR - Argentina 87
CA - Canada 62
MX - Messico 58
NL - Olanda 46
TR - Turchia 46
ZA - Sudafrica 43
EC - Ecuador 41
AT - Austria 40
IQ - Iraq 38
JP - Giappone 38
CO - Colombia 35
MA - Marocco 29
UZ - Uzbekistan 27
ES - Italia 26
ID - Indonesia 26
BE - Belgio 25
VE - Venezuela 22
PY - Paraguay 21
CL - Cile 19
PK - Pakistan 19
AZ - Azerbaigian 18
KZ - Kazakistan 16
AU - Australia 15
KE - Kenya 14
NP - Nepal 14
PE - Perù 14
JO - Giordania 13
SA - Arabia Saudita 13
PH - Filippine 11
TN - Tunisia 11
AL - Albania 10
MY - Malesia 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 8
IL - Israele 8
NI - Nicaragua 8
DO - Repubblica Dominicana 7
EG - Egitto 7
LT - Lituania 7
SN - Senegal 7
CH - Svizzera 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
GE - Georgia 6
NO - Norvegia 6
OM - Oman 6
RS - Serbia 6
BO - Bolivia 5
GA - Gabon 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
RO - Romania 5
SY - Repubblica araba siriana 5
AO - Angola 4
BY - Bielorussia 4
DZ - Algeria 4
GT - Guatemala 4
IR - Iran 4
KG - Kirghizistan 4
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
KW - Kuwait 3
TW - Taiwan 3
AM - Armenia 2
BW - Botswana 2
CI - Costa d'Avorio 2
GY - Guiana 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
Totale 25.430
Salva come PNG Salva come JPEG
Città #
Moscow 1.579
Singapore 1.326
Dublin 1.165
Ashburn 1.090
Chandler 934
Dallas 794
Jacksonville 763
Hong Kong 624
Nyköping 502
Beijing 444
San Jose 424
Princeton 218
The Dalles 214
Lauterbourg 202
Dearborn 191
Los Angeles 184
Cambridge 182
Des Moines 172
Messina 144
Medford 141
São Paulo 127
Buffalo 122
Boardman 112
Lancaster 111
Munich 105
Ho Chi Minh City 97
Ann Arbor 93
Warsaw 93
Woodbridge 68
Frankfurt am Main 60
Redondo Beach 60
Jinan 58
Tianjin 58
Rio de Janeiro 56
Hanoi 54
Wilmington 53
New York 50
Bremen 48
Council Bluffs 48
Guangzhou 48
Shenyang 48
Belo Horizonte 42
San Mateo 41
Orem 40
Seattle 39
Santa Clara 38
Nuremberg 36
Turku 35
Tokyo 34
Brooklyn 28
Chennai 28
Houston 28
Zhengzhou 28
Curitiba 26
Hebei 26
London 26
Brasília 25
Shenzhen 25
Brussels 24
Vienna 24
Nanjing 23
Ningbo 23
Campinas 22
Catania 22
Tashkent 22
Amsterdam 20
Denver 19
San Francisco 19
Shanghai 19
Stockholm 19
Chicago 18
Dhaka 18
Haikou 18
Helsinki 18
Changsha 17
Hangzhou 17
Porto Alegre 17
Washington 17
Baghdad 16
Baku 16
Boston 16
Johannesburg 16
Atlanta 15
Düsseldorf 15
Hyderabad 15
Manchester 15
Mexico City 15
Rome 15
Bogotá 14
Jiaxing 14
Milan 14
Phoenix 14
Taizhou 14
Poplar 13
Fortaleza 12
Guayaquil 12
Montreal 12
Nanchang 12
Osasco 12
Quito 12
Totale 14.112
Salva come PNG Salva come JPEG
Nome #
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 212
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 207
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 194
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 191
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 189
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 183
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 180
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 177
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 176
Alexithymia and inflammatory bowel disease: A systematic review 176
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 174
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 173
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 172
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 169
OCT Performance in the Diagnosis of Ulcerative Colitis 166
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 166
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 166
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 158
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 158
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 157
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 157
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 156
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 156
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 155
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 155
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 154
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 154
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 152
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 151
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 151
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 151
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 149
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 147
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 147
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 146
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 146
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 145
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 144
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 143
The aged gut in inflammatory bowel diseases. 143
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 142
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 141
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 141
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 141
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 141
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 141
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 140
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 140
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 140
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 139
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 138
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 137
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 137
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 135
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 135
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 134
Clinical practice in the management of ulcerative colitis - an Italian survey 133
Mucosal Immunology and Probiotics. 133
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 133
Vitamin D and inflammatory bowel disease 132
IBD-associated bone loss: is inflammation the explanation? 131
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 131
Metacognition and negative emotions in clinical practice. A preliminary study with patients with bowel disorder 131
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 130
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 130
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 130
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 129
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 129
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 129
Hongos productores de biopelículas como causa emergente de infecciones por vía hemática en la enfermedad inflamatoria intestinal 129
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 128
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy 128
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 126
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions. 126
Acute onset of Lupus associated Pancreatitis Mimicking Pancreatic Cancer 126
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 126
Experimental colitis increases small intestine permeability in the rat 125
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 125
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 124
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 123
Comment to "Management of cytomegalovirus infection in inflammatory bowel diseases" 122
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study 122
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 120
Predicting response to thiopurines – a single centre experience. 120
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 119
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 119
Treatment of life threatening type I refractory celiac disease with long term infliximab 118
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 118
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 116
Effects of anti COX-2, nabumetone and aspirin on gastric and intestinal permeability on healthy volunteers 116
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 115
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial 115
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease 114
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 114
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 111
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study 111
Extra-gastric effects of highly selective vagotomy. Bone and mineral metabolism in the rat. 111
A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy 108
Microradiographic anatomy of the explanted rat colon 108
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 108
Totale 14.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/20221.406 8 190 30 40 45 15 62 46 15 333 194 428
2022/20233.388 301 272 153 299 284 319 39 177 1.404 17 89 34
2023/2024790 69 116 87 130 89 102 21 30 2 69 8 67
2024/20254.374 64 56 129 231 255 196 147 885 1.110 224 338 739
2025/202611.952 464 764 864 751 973 2.700 1.527 1.572 1.481 496 196 164
Totale 25.898